SCHEMBL4581496

SCHEMBL4581496

CCNN(NCC)C(=S)Nc1ccc(N(C(C)=O)N2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.42
ALDH1A1 P00352 3/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 3/20 0.38
KMT2A Q03164 5/20 0.37
ATM Q13315 1/20 0.36
GFER P55789 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ALOX12 P18054 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MEN1 O00255 4/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
GAA P10253 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4581605 0.83 MAPT (0.42) MAPTALDH1A1LMNAPOLBATM
SCHEMBL4581596 0.75 SLC6A9 (0.39) MAPTALDH1A1LMNAGFER
SCHEMBL8723002 0.74 SLC6A9 (0.38) MAPTALDH1A1LMNAGFER
SCHEMBL4581507 0.73 S1PR1 (0.37) MAPTALDH1A1POLBKMT2AKDM4E
SCHEMBL8722452 0.72 MAPT (0.37) MAPTALDH1A1LMNAPOLBGFER
SCHEMBL8719314 0.71 HSD17B10 (0.39) ALOX12CYP1A2CYP3A4TP53
SCHEMBL8722985 0.69 S1PR1 (0.43) MAPTALDH1A1LMNAPOLBKMT2A
SCHEMBL8719295 0.69 POLB (0.47) MAPTALDH1A1LMNAPOLBKMT2A
SCHEMBL8722938 0.66 AAK1 (0.40) MAPTALDH1A1LMNAPOLBKMT2A
SCHEMBL8723014 0.66 MAPT (0.36) MAPTALDH1A1LMNAPOLBATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030171561-A1 Aminocarboxylate ligands having substituted aromatic amide moieties BRACCO SUISSE SA (CH) 2003-09-11 US claimed
US-7351389-B2 Aminocarboxylate ligands having substituted aromatic amide moieties BRACCO INTERNATIONAL B.V. (NL) 2008-04-01 US disclosed
US-20050090689-A1 Aminocarboxylate ligands having substituted aromatic amide moieties BRACCO INTERNATIONAL B.V. (NL) 2005-04-28 US disclosed
US-6875864-B2 Aminocarboxylate ligands having substituted aromatic amide moieties BRACCO INTERNATIONAL B.V. (NL) 2005-04-05 US disclosed
US-20030171561-A1 Aminocarboxylate ligands having substituted aromatic amide moieties BRACCO SUISSE SA (CH) 2003-09-11 US disclosed
EP-0543482-B1 Aminocarboxylate ligands having substituted aromatic amide moieties BRACCO INT BV (NL) 2002-02-06 EP disclosed
EP-0543482-A1 Aminocarboxylate ligands having substituted aromatic amide moieties BRACCO INTERNATIONAL B.V. (NL) 1993-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030171561-A1 Aminocarboxylate ligands having substituted aromatic amide moieties ARGLU1, PRMT1, AADAC MAPT 2319/4885ALDH1A1 741/4885LMNA 3524/4885
US-20050090689-A1 Aminocarboxylate ligands having substituted aromatic amide moieties AADAC, ANXA3, AAAS MAPT 1746/4885ALDH1A1 691/4885LMNA 2658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.